Filter Results
:
(218)
Show Results For
-
All HBS Web
(1,552)
- Faculty Publications (218)
Show Results For
-
All HBS Web
(1,552)
- Faculty Publications (218)
- 2022
- Working Paper
THEMIS: A Framework for Cost-Benefit Analysis of COVID-19 Non-Pharmaceutical Interventions
By: Dimitris Bertsimas, Michael Lingzhi Li and Saksham Soni
Since December 2019, the world has been ravaged by the COVID-19 pandemic, with over 150 million confirmed cases and 3 million confirmed deaths worldwide. To combat the spread of COVID-19, governments have issued unprecedented non-pharmaceutical interventions (NPIs),...
View Details
Keywords:
COVID-19;
Health Pandemics;
Policy;
Framework;
Cost vs Benefits;
Outcome or Result;
United States;
Germany;
Brazil;
Singapore;
Spain
Bertsimas, Dimitris, Michael Lingzhi Li, and Saksham Soni. "THEMIS: A Framework for Cost-Benefit Analysis of COVID-19 Non-Pharmaceutical Interventions." Working Paper, April 2022.
- December 2021
- Case
Grace Capital
By: Sara Fleiss, Robin Greenwood, Eren Kuzucu and Denise Han
In March 2020, the global pandemic was delivering a dose of volatility to the U.S. economy. Catherine Faddis, the CIO of Grace Capital, a Boston-based long-only equity manager, analyzed movements in her portfolio while eyeing previously shelved opportunities to invest...
View Details
Keywords:
Preferred Stock;
COVID-19 Pandemic;
Economy;
Health Pandemics;
Volatility;
Entrepreneurship;
Finance;
Investment;
Strategy;
Decision Making;
Investment Portfolio;
Financial Services Industry;
United States
Fleiss, Sara, Robin Greenwood, Eren Kuzucu, and Denise Han. "Grace Capital." Harvard Business School Case 222-052, December 2021.
- November 2021 (Revised May 2022)
- Case
West Virginia: Finding the Right Path Forward
By: Matthew C. Weinzierl, Christine Keung and Reggie Smith
Once at the center of the American economy, the state of West Virginia had seen decades of decline as its coal industry fell on hard times. With beautiful but challenging topography, a proud but shrinking population, and a new scourge of the opioid epidemic, the...
View Details
Keywords:
Population Health;
Geographic Location;
Economic Slowdown and Stagnation;
Problems and Challenges;
Social Issues;
West Virginia
Weinzierl, Matthew C., Christine Keung, and Reggie Smith. "West Virginia: Finding the Right Path Forward." Harvard Business School Case 722-024, November 2021. (Revised May 2022.)
- 2021
- Working Paper
COVID-19, Government Performance, and Democracy: Survey Experimental Evidence from 12 Countries
By: Michael Becher, Nicholas Longuet Marx, Vincent Pons, Sylvain Brouard, Martial Foucault, Vincenzo Galasso, Eric Kerrouche, Sandra León Alfonso and Daniel Stegmueller
Beyond its immediate impact on public health and the economy, the COVID-19 pandemic has put democracy under stress. While a common view is that people should blame the government rather than the political system for bad crisis management, an opposing view is that...
View Details
Keywords:
COVID-19 Pandemic;
Government Performance;
Democracy;
Health Pandemics;
Government and Politics;
Crisis Management;
Public Opinion
Becher, Michael, Nicholas Longuet Marx, Vincent Pons, Sylvain Brouard, Martial Foucault, Vincenzo Galasso, Eric Kerrouche, Sandra León Alfonso, and Daniel Stegmueller. "COVID-19, Government Performance, and Democracy: Survey Experimental Evidence from 12 Countries." NBER Working Paper Series, No. 29514, November 2021. (Revise and resubmit requested, The Journal of Politics.)
- 2021
- Article
Don't Get It or Don't Spread It: Comparing Self-interested versus Prosocial Motivations for COVID-19 Prevention Behaviors
By: Jillian J. Jordan, Erez Yoeli and David Rand
COVID-19 prevention behaviors may be seen as self-interested or prosocial. Using American samples from MTurk and Prolific (total n = 6,850), we investigated which framing is more effective—and motivation is stronger—for fostering prevention behavior intentions. We...
View Details
Keywords:
COVID-19;
Prevention;
Prosocial Motivation;
Health Pandemics;
Behavior;
Motivation and Incentives
Jordan, Jillian J., Erez Yoeli, and David Rand. "Don't Get It or Don't Spread It: Comparing Self-interested versus Prosocial Motivations for COVID-19 Prevention Behaviors." Art. 20222. Scientific Reports 11 (2021).
- September 2021 (Revised October 2022)
- Supplement
Hester Pharmaceuticals (B): Securing Supply
By: Dante Roscini and John Masko
Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was...
View Details
Keywords:
COVID-19 Pandemic;
Cost vs Benefits;
Trade;
Supply Chain;
Global Strategy;
Buildings and Facilities;
Operations;
Health Care and Treatment;
Demand and Consumers;
Global Range;
Globalized Markets and Industries;
Pharmaceutical Industry;
Italy;
China;
United States;
Germany
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (B): Securing Supply." Harvard Business School Supplement 722-009, September 2021. (Revised October 2022.)
- 2021
- Case
Leading Through Challenging Times: Atlanta Mayor Keisha Lance Bottoms
By: Michael Norris, Rawi Abdelal and Kimberlyn Leary
Keisha Lance Bottoms took office as Mayor of Atlanta in 2018 with a progressive agenda and hopes to “keep Atlanta moving forward, leaving no one behind.” She was an Atlanta native, had previously served as a local judge and city councilor, and came into office with...
View Details
Keywords:
Leadership;
City;
Problems and Challenges;
Health Pandemics;
Social Issues;
Economy;
Atlanta;
United States
Norris, Michael, Rawi Abdelal, and Kimberlyn Leary. "Leading Through Challenging Times: Atlanta Mayor Keisha Lance Bottoms." Bloomberg Harvard City Leadership Initiative Case 0036TC, 2021.
- July 2021
- Teaching Note
Digital Transformation 2.0: CEO Elie Girard at Atos
By: Tsedal Neeley
Teaching Note for HBS Case No. 421-024. Elie Girard has taken the helm as CEO of multinational IT giant Atos to lead the company into the next era of digital transformation. Noticing that customers’ digital needs were evolving to become even more specialized and global...
View Details
- 2021
- Working Paper
Nonbank Lending and Credit Cyclicality
By: Quirin Fleckenstein, Manasa Gopal, German Gutierrez and Sebastian Hillenbrand
We document three facts about nonbank lending in the syndicated loan market. First, nonbank lending is more than twice as cyclical as bank lending. Second, declines in nonbank lending explain most of the declines in syndicated lending during the Great Recession and...
View Details
Keywords:
Nonbank Lending;
Credit Cycles;
CLO;
Mutual Funds;
Leveraged Lending;
COVID-19;
Great Migration;
Non-bank Financial Institutions;
Financing and Loans;
Business Cycles
Fleckenstein, Quirin, Manasa Gopal, German Gutierrez, and Sebastian Hillenbrand. "Nonbank Lending and Credit Cyclicality." Working Paper, June 2021.
- May 13, 2021
- Article
How to Lead in the Stakeholder Era
By: Hubert Joly
The world is clearly facing multifaceted crises: a health crisis, an economic crisis, a societal crisis, a racial crisis, an environmental crisis, and rising geopolitical tensions. In the face of these challenges, there is a growing realization that business and...
View Details
Keywords:
Business And Society;
Stakeholder Capitalism;
Leadership;
Business and Stakeholder Relations
Joly, Hubert. "How to Lead in the Stakeholder Era." Harvard Business Review (website) (May 13, 2021).
- May 2021
- Article
Preparing for a Pandemic: Accelerating Vaccine Availability
By: Amrita Ahuja, Susan Athey, Arthur Baker, Eric Budish, Juan Camilo Castillo, Rachel Glennerster, Scott Duke Kominers, Michael Kremer, Jean Lee, Canice Prendergast, Christopher M. Snyder, Alex Tabarrok, Brandon Joel Tan and Witold Wiecek
Vaccinating the world’s population quickly in a pandemic has enormous health and economic benefits. We analyze the problem faced by governments in determining the scale and structure of procurement for vaccines. We analyze alternative approaches to procurement, arguing...
View Details
Keywords:
Vaccines;
Procurement;
Health Pandemics;
Health Care and Treatment;
Acquisition;
Cooperation
Ahuja, Amrita, Susan Athey, Arthur Baker, Eric Budish, Juan Camilo Castillo, Rachel Glennerster, Scott Duke Kominers, Michael Kremer, Jean Lee, Canice Prendergast, Christopher M. Snyder, Alex Tabarrok, Brandon Joel Tan, and Witold Wiecek. "Preparing for a Pandemic: Accelerating Vaccine Availability." AEA Papers and Proceedings 111 (May 2021): 331–335.
- April 2021 (Revised December 2023)
- Case
The Mahindra Group: Leading with Purpose
By: Ranjay Gulati and Rachna Tahilyani
India headquartered Mahindra Group is a multibillion-dollar federation of companies operating across the globe. It is ahead of its time in articulating its purpose and mapping its values, something it had first done at inception and then refreshed yet again as ‘Rise’...
View Details
Keywords:
Mission and Purpose;
Organizational Culture;
Change Management;
Communication Strategy;
Family Ownership;
Corporate Social Responsibility and Impact;
Revenue;
Auto Industry;
Financial Services Industry;
Manufacturing Industry;
Technology Industry;
Asia;
India;
Mumbai;
South Korea;
Italy;
United States
Gulati, Ranjay, and Rachna Tahilyani. "The Mahindra Group: Leading with Purpose." Harvard Business School Case 421-091, April 2021. (Revised December 2023.)
- March 2021
- Case
Yale Investments Office: November 2020
By: Josh Lerner, Jo Tango and Alys Ferragamo
David Swensen and the Investments Office staff must decide whether to continue to allocate the bulk of the university's endowment to illiquid investments—hedge funds, private equity, venture capital, real estate, natural resources—given the impact of the COVID-19...
View Details
Keywords:
University Endowment;
Asset Allocation;
Real Estate;
Equities;
Fixed Income;
COVID-19;
Asset Management;
Private Equity;
Venture Capital;
Natural Resources;
Resource Allocation;
Investment;
Investment Portfolio;
Health Pandemics;
Financial Crisis;
Financial Services Industry;
Real Estate Industry;
Energy Industry;
Connecticut
Lerner, Josh, Jo Tango, and Alys Ferragamo. "Yale Investments Office: November 2020." Harvard Business School Case 821-074, March 2021.
- March 2021 (Revised January 2023)
- Case
The Trouble with TCE
By: Vincent Pons, Rafael Di Tella and Galit Goldstein
Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other...
View Details
Keywords:
Trichloroethylene;
Toxicity;
Lobbying;
Chemicals;
Health Disorders;
Governing Rules, Regulations, and Reforms;
Policy;
Ethics;
Business and Government Relations;
Chemical Industry;
United States
Pons, Vincent, Rafael Di Tella, and Galit Goldstein. "The Trouble with TCE." Harvard Business School Case 721-031, March 2021. (Revised January 2023.)
- Article
Internal Deadlines, Drug Approvals, and Safety Problems
By: Lauren Cohen, Umit Gurun and Danielle Li
Absent explicit quotas, incentives, reporting, or fiscal year-end motives, drug approvals around the world surge in December, at month-ends, and before respective major national holidays. Drugs approved before these informal deadlines are associated with significantly...
View Details
Keywords:
Health;
Economics;
Government and Politics;
Innovation and Invention;
Research;
Science;
Health Industry;
Health Industry;
Health Industry
Cohen, Lauren, Umit Gurun, and Danielle Li. "Internal Deadlines, Drug Approvals, and Safety Problems." American Economic Review: Insights 3, no. 1 (March 2021): 67–82.
- February 2021 (Revised March 2023)
- Supplement
The Coronavirus (COVID-19) Pandemic and the Global Economy (B)
By: Alberto Cavallo and Christian Godwin
By December 2020, the COVID-19 pandemic had swept across the globe, creating widespread disruption in all aspects of everyday life. Almost 90 million people had been infected and nearly two million had died from the disease. By this point in the pandemic—a year since...
View Details
Keywords:
COVID-19 Pandemic;
Economy;
Health Pandemics;
Economic Slowdown and Stagnation;
Global Range;
Crisis Management;
Disruption
Cavallo, Alberto, and Christian Godwin. "The Coronavirus (COVID-19) Pandemic and the Global Economy (B)." Harvard Business School Supplement 721-434, February 2021. (Revised March 2023.)
- 2021
- Chapter
Sostenibilidad y negocios verdes en América Latina
By: Geoffrey Jones
This chapter in the first-ever business history textbook on Latin America examines the impact of modern business enterprise on the natural environment of the region between the 19th century and the present day. It argues that although global capitalism created much...
View Details
Keywords:
Environment;
Business History;
Environmental Sustainability;
Latin America;
North and Central America
Jones, Geoffrey. "Sostenibilidad y negocios verdes en América Latina." Chap. 7 in Historia empresarial en América Latina: temas, debates y problemas, edited by Andrea Lluch, Martín Monsalve Zanatti, and Marcelo Bucheli, 171–194. Bogotá, Colombia: Universidad de los Andes, 2021, Spanish ed.
- January 2021 (Revised June 2021)
- Case
Hester Pharmaceuticals (A): A Pricing Dilemma
By: Dante Roscini and John Masko
In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a...
View Details
Keywords:
Macroeconomics;
Trade;
Price;
Global Range;
Global Strategy;
Globalized Markets and Industries;
Health Care and Treatment;
Patents;
Monopoly;
Negotiation;
Business and Government Relations;
Risk and Uncertainty;
Human Needs;
Business Strategy;
Commercialization;
Pharmaceutical Industry;
Italy
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (A): A Pricing Dilemma." Harvard Business School Case 721-001, January 2021. (Revised June 2021.)
- January 2021
- Case
Digital Transformation 2.0: CEO Elie Girard at Atos
By: Tsedal Neeley and James Barnett
Elie Girard has taken the helm as CEO of Atos—multinational IT giant—to lead the company into the next era of digital transformation. Noticing that customers’ digital needs were evolving to become even more specialized and global in scope, he made a bold first step as...
View Details
Neeley, Tsedal, and James Barnett. "Digital Transformation 2.0: CEO Elie Girard at Atos." Harvard Business School Case 421-024, January 2021.
- June 2021
- Article
From Predictions to Prescriptions: A Data-driven Response to COVID-19
By: Dimitris Bertsimas, Léonard Boussioux, Ryan Cory-Wright, Arthur Delarue, Vassilis Digalakis Jr, Alexander Jacquillat, Driss Lahlou Kitane, Galit Lukin, Michael Lingzhi Li, Luca Mingardi, Omid Nohadani, Agni Orfanoudaki, Theodore Papalexopoulos, Ivan Paskov, Jean Pauphilet, Omar Skali Lami, Bartolomeo Stellato, Hamza Tazi Bouardi, Kimberly Villalobos Carballo, Holly Wiberg and Cynthia Zeng
The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at...
View Details
Keywords:
COVID-19;
Health Pandemics;
AI and Machine Learning;
Forecasting and Prediction;
Analytics and Data Science
Bertsimas, Dimitris, Léonard Boussioux, Ryan Cory-Wright, Arthur Delarue, Vassilis Digalakis Jr, Alexander Jacquillat, Driss Lahlou Kitane, Galit Lukin, Michael Lingzhi Li, Luca Mingardi, Omid Nohadani, Agni Orfanoudaki, Theodore Papalexopoulos, Ivan Paskov, Jean Pauphilet, Omar Skali Lami, Bartolomeo Stellato, Hamza Tazi Bouardi, Kimberly Villalobos Carballo, Holly Wiberg, and Cynthia Zeng. "From Predictions to Prescriptions: A Data-driven Response to COVID-19." Health Care Management Science 24, no. 2 (June 2021): 253–272.